A comparison of multifaceted versus Clostridium difficile-Focused VRE surveillance strategies in a low-prevalence setting

Infection Control and Hospital Epidemiology

Volumn 22, Issue 4, 2001, Pages 219-221

  Katz, Kevin C ^a   Gardam, Michael A ^a   Burt, JoAnne ^a   Conly, John M ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CLOSTRIDIUM DIFFICILE; COST CONTROL; ENTEROCOCCUS; FECES ANALYSIS; INFECTION RISK; SCREENING TEST;

EID: 0035031711     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501896     Document Type: Article

References (10)

1. Conly JM, Ofner ME, Paton S. The emerging epidemiology of vancomycin resistant enterococci in Canada, 1993-1998: results from the Canadian Nosocomial Injection Surveillance Program (CNISP) passive reporting network. Can J Infect Dis 1999;10(suppl D):38D.
2. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee. MMWR 1995;44(RR-12):1-13.
3. Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999;29:361-366.
4. Montecalvo M, de Lencastre H, Carraher M, Gedris C, Chung M, VanHorn K, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16: 680-685.
5. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731-734.
6. Rosner B. Fundamentals of Biostatistics. 3rd ed. Boston, MA: PWS-Kent Pubs Co; 1990:366-372.
7. Roghmann MC, McCarter RJ, Brewrink J, Cross AS, Morris JG. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis 1997;25:1056-1059.
8. Gerding D. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997;25(suppl 2):S206-S210.
9. Rafferty ME, McCormick MI, Bopp LH, Baltch AL, George M, Smith RP, et al. Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay. Infect Control Hosp Epidemiol 1997;18:342-344.
10. Boyce JM, Mermel LA, Zervos JM, Rice L, Potter-Bynoe G, Giorgio C, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995;16:634-637.